IL-7 may up-regulate tumor-directed immune responses in a number of ways, including, but not limited to, enhancement of the cellular (Th1) immune response or selective expansion of the tumor-redirected cytotoxic T lymphocytes [8, 9, 11, 12]. The gene discussed is IL7; the disease is neoplasm.